Details van artikel 237 van 592 gevonden artikelen
444PD Patient-reported outcomes (PROs) in ASCEND-5: A randomized, phase 3 study of ceritinib vs chemotherapy (CT) in patients (pts) with advanced anaplastic lymphoma kinase rearranged (ALK+) NSCLC previously treated with CT and crizotinib (CRZ)
Titel:
444PD Patient-reported outcomes (PROs) in ASCEND-5: A randomized, phase 3 study of ceritinib vs chemotherapy (CT) in patients (pts) with advanced anaplastic lymphoma kinase rearranged (ALK+) NSCLC previously treated with CT and crizotinib (CRZ)
Auteur:
Mok, T.S.K. Scagliotti, G. Kim, T.M. Crino, L. Liu, G. Gridelli, C. Novello, S. Kiura, K. Bearz, A. Gautschi, O. Felip, E. Nishio, M. Spigel, D.R. Urban, P. Deudon, S. Zheng, C. Shaw, A.T.
Verschenen in:
Annals of oncology
Paginering:
Jaargang 27 () nr. S9 pagina's ix142-ix143
Jaar:
2016
Inhoud:
Uitgever:
European Society for Medical Oncology
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 237 van 592 gevonden artikelen